{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:06:33Z","timestamp":1787317593038,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    (\n                    <jats:italic>T. gondii<\/jats:italic>\n                    ) infection continues to rise globally in humans and animals with high socioeconomic and public health challenges. Current medications used against\n                    <jats:italic>T. gondii<\/jats:italic>\n                    infection are limited in efficacy, safety, and affordability. This research was conducted to assess the higher fungi extract effect on\n                    <jats:italic>T. gondii<\/jats:italic>\n                    tachyzoites growth in vitro and possibly decipher its mechanism of action. Furthermore, we evaluated the extract's effect on human foreskin fibroblast viability. The methanol extracts of Turkey tail (TT) mushroom was tested against\n                    <jats:italic>T. gondii<\/jats:italic>\n                    tachyzoites growth using an RH-RFP type I strain that expresses red fluorescent protein throughout culture in a dose-dependent manner using a fluorescent plate reader. Similarly, we tested the effect of the extract on host cell viability. We observed that TT extract inhibited tachyzoites growth with a 50% minimum inhibitory concentration (IC\n                    <jats:sub>50s<\/jats:sub>\n                    ), IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009=\u20095.98\u2009\u00b1\u20091.22\u00a0\u00b5g\/mL, and 50% cytotoxic concentration (CC\n                    <jats:sub>50s<\/jats:sub>\n                    ), CC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009\u2265\u2009100\u00a0\u00b5g\/mL. It was discovered that TT extract induced strong mitochondria superoxide and\u00a0 reactive oxygen species\u00a0production and disrupted mitochondria membrane potential in\n                    <jats:italic>T. gondii<\/jats:italic>\n                    tachyzoites. Additionally, scanning electron microscopy depicted that TT extract and pyrimethamine (PY) caused a morphological deformation of tachyzoites in vitro\n                    <jats:italic>.<\/jats:italic>\n                    In conclusion, TT methanol extract made up of phytosterols, bioactive sphingolipids, peptides, phenolic acids, and lactones could be a promising source of new compounds for the future development of anti-\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    drugs. Extracts were non-cytotoxic, even at higher concentrations.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-35676-6","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T06:03:33Z","timestamp":1685340213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anti-Toxoplasma gondii activity of Trametes versicolor (Turkey tail) mushroom extract"],"prefix":"10.1038","volume":"13","author":[{"given":"Homa Nath","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Catrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogechi Destiny","family":"Nwokeocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boakai K.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Abugri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,29]]},"reference":[{"key":"35676_CR1","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1017\/S0031182021001463","volume":"148","author":"JP Dubey","year":"2021","unstructured":"Dubey, J. P., Murata, F. H. A., Cerqueira-C\u00e9zar, C. K., Kwok, O. C. H. & Villena, I. Congenital toxoplasmosis in humans: An update of the worldwide rate of congenital infections. Parasitology 148, 1716 (2021).","journal-title":"Parasitology"},{"key":"35676_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas, G., Roussos, N. & Falagas, M. E. Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39, 1385\u20131394 (2009).","journal-title":"Int. J. Parasitol."},{"key":"35676_CR3","doi-asserted-by":"publisher","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr, J., Prandota, J., Sovi\u010dkov\u00e1, M. & Israili, Z. H. Toxoplasmosis\u2013a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE 9, e90203 (2014).","journal-title":"PLoS ONE"},{"key":"35676_CR4","unstructured":"CDC. Parasites-toxoplasmosis (toxoplasma infection): Epidemiology and risk. Retrieved from CDC: Centers for Disease Control Prevention: https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/epi.html. Accessed 01 May 2023 (2023)."},{"key":"35676_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-020-3954-1","volume":"13","author":"M Montazeri","year":"2020","unstructured":"Montazeri, M. et al. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967\u20132017): A systematic review and meta-analysis. Parasites Vectors 13, 1\u201310 (2020).","journal-title":"Parasites Vectors"},{"key":"35676_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80569-7","volume":"11","author":"AM Shammaa","year":"2021","unstructured":"Shammaa, A. M., Powell, T. G. & Benmerzouga, I. Adverse outcomes associated with the treatment of Toxoplasma infections. Sci. Rep. 11, 1\u20138 (2021).","journal-title":"Sci. Rep."},{"key":"35676_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3201\/eid2504.181689","volume":"25","author":"D Shiojiri","year":"2019","unstructured":"Shiojiri, D., Kinai, E., Teruya, K., Kikuchi, Y. & Oka, S. Combination of clindamycin and azithromycin as alternative treatment for Toxoplasma gondii encephalitis. Emerg. Infect. Dis. 25, 841 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"35676_CR8","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/molecules25071574","volume":"25","author":"A Secrieru","year":"2020","unstructured":"Secrieru, A., Costa, I. C., O\u2019Neill, P. M. & Cristiano, M. L. Antimalarial agents as therapeutic tools against toxoplasmosis\u2014A short bridge between two distant illnesses. Molecules 25, 1574 (2020).","journal-title":"Molecules"},{"key":"35676_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5114","volume":"351","author":"M McCarthy","year":"2015","unstructured":"McCarthy, M. Drug\u2019s 5000% price rise puts spotlight on soaring US drug costs. BMJ 351, h5114 (2015).","journal-title":"BMJ"},{"key":"35676_CR10","doi-asserted-by":"crossref","unstructured":"Mkhize, S. S., Machaba, K. E., Simelane, M. B. & Pooe, O. J. Mushroom\u2010derived products as an alternative antimalarial therapeutics: A Review. Drug Dev Malaria Novel Approaches Prev Treat. 235\u2013249 (2022).","DOI":"10.1002\/9783527830589.ch10"},{"key":"35676_CR11","doi-asserted-by":"crossref","unstructured":"Abugri, D. A. et al. Medicinal mushrooms as novel sources for new antiparasitic drug development. In Medicinal Mushrooms 251\u2013273 (Springer, Singapore, 2019a).","DOI":"10.1007\/978-981-13-6382-5_9"},{"key":"35676_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cbdd.13070","volume":"91","author":"DA Abugri","year":"2018","unstructured":"Abugri, D. A., Witola, W. H., Russell, A. E. & Troy, R. M. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii. Chem Biol Drug Des 91, 194\u2013201 (2018).","journal-title":"Chem Biol Drug Des"},{"key":"35676_CR13","first-page":"2167","volume":"6","author":"JL Powers","year":"2017","unstructured":"Powers, J. L., Zhang, X., Kim, C. Y., Abugri, D. A. & Witola, W. H. Activity of green algae extracts against Toxoplasma gondii. Med Aromat Plants (Los Angels) 6, 2167\u20132412 (2017).","journal-title":"Med Aromat Plants (Los Angels)"},{"key":"35676_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2472-0542.1000108","volume":"2","author":"D Abugri","year":"2016","unstructured":"Abugri, D., McElhenney, W. H. & Willian, K. R. Fatty acid profiling in selected cultivated edible and wild medicinal mushrooms in the Southern United States. J. Exp. Food Chem. 2, 1\u20137 (2016).","journal-title":"J. Exp. Food Chem."},{"key":"35676_CR15","doi-asserted-by":"crossref","unstructured":"Leliebre-Lara, V., Garc\u00eda, M., Nogueiras, C. & Monzote, L. Qualitative analysis of an ethanolic extract from Trametes versicolor and biological screening against Leishmania amazonensis. Emirates J. Food Agric. 592\u2013595 (2015).","DOI":"10.9755\/ejfa.2015.05.194"},{"key":"35676_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/molecules21081045","volume":"21","author":"V Leliebre-Lara","year":"2016","unstructured":"Leliebre-Lara, V. et al. In vitro antileishmanial activity of sterols from Trametes versicolor (Bres. Rivarden). Molecules 21, 1045 (2016).","journal-title":"Molecules"},{"key":"35676_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ptr.3653","volume":"26","author":"A Ramos-Ligonio","year":"2012","unstructured":"Ramos-Ligonio, A., L\u00f3pez-Monteon, A. & Trigos, \u00c1. Trypanocidal activity of ergosterol peroxide from Pleurotus ostreatus. Phytother. Res. 26, 938\u2013943 (2012).","journal-title":"Phytother. Res."},{"key":"35676_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1021\/np030372w","volume":"67","author":"KZ Jordan","year":"2004","unstructured":"Jordan, K. Z. Biologically active compounds from Aphyllophorales (Polypore) Fungi. J. Nat. Prod. 67, 300\u2013310 (2004).","journal-title":"J. Nat. Prod."},{"key":"35676_CR19","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/S0040-4020(01)82446-7","volume":"39","author":"J Valisolalao","year":"1983","unstructured":"Valisolalao, J., Luu, B. & Ourisson, G. Steroides cytotoxiques de polyporus versicolor. Tetrahedron 39, 2779\u20132785 (1983).","journal-title":"Tetrahedron"},{"key":"35676_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1615\/IntJMedMushrooms.v17.i3.50","volume":"17","author":"E Habibi","year":"2015","unstructured":"Habibi, E., Sadat-Ebrahimi, S. E., Mousazadeh, S. A. & Amanzadeh, Y. Mycochemical investigation of the Turkey tail medicinal mushroom Trametes versicolor (Higher basidiomicetes): A potential application of isolated compounds in documented pharmacological studies. Int. J. Med. Mushrooms 17, 255\u2013265 (2015).","journal-title":"Int. J. Med. Mushrooms"},{"key":"35676_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4732-z","volume":"12","author":"DA Abugri","year":"2019","unstructured":"Abugri, D. A., Jaynes, J. M. & Witola, W. H. Anti-Toxoplasma activity of Sorghum bicolor-derived lipophilic fractions. BMC Res. Notes 12, 1\u20137 (2019).","journal-title":"BMC Res. Notes"},{"key":"35676_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.exppara.2016.02.001","volume":"164","author":"DA Abugri","year":"2016","unstructured":"Abugri, D. A., Witola, W. H., Jaynes, J. M. & Toufic, N. In vitro activity of Sorghum bicolor extracts, 3-deoxyanthocyanidins, against Toxoplasma gondii. Exp. Parasitol. 164, 12\u201319 (2016).","journal-title":"Exp. Parasitol."},{"key":"35676_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s12161-011-9356-4","volume":"5","author":"DA Abugri","year":"2012","unstructured":"Abugri, D. A., McElhenney, W. H. & Willian, K. R. Comparison of transesterification methods for fatty acid analysis in higher fungi: Application to mushrooms. Food Anal. Methods 5, 1159\u20131166 (2012).","journal-title":"Food Anal. Methods"},{"key":"35676_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0305-7372(84)90005-7","volume":"2","author":"S Tsukagoshi","year":"1984","unstructured":"Tsukagoshi, S. et al. Krestin (PSK). Cancer Treat. Rev. 2, 131\u2013155 (1984).","journal-title":"Cancer Treat. Rev."},{"key":"35676_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0192-0561(94)90068-X","volume":"16","author":"S Yunoki","year":"1994","unstructured":"Yunoki, S., Tanaka, N., Hizuta, A. & Orita, K. Enhancement of antitumor cytotoxicity of hepatic lymphocytes by oral administration of PSK. Int. J. Immunopharmacol. 16, 123\u2013130 (1994).","journal-title":"Int. J. Immunopharmacol."},{"key":"35676_CR26","volume":"3","author":"LAC Nascimento","year":"2022","unstructured":"Nascimento, L. A. C. et al. The ethanolic extract of the fungus Trichoderma stromaticum decreases the Toxoplasma gondii replication in vitro and ameliorates the experimental toxoplasmosis in vivo. Curr. Res. Microb. Sci. 3, 100173 (2022).","journal-title":"Curr. Res. Microb. Sci."},{"key":"35676_CR27","first-page":"37","volume":"3","author":"DA Abugri","year":"2013","unstructured":"Abugri, D. A. & McElhenney, W. H. Extraction of total phenolic and flavonoids from edible wild and cultivated medicinal mushrooms as affected by different solvents. J. Nat. Prod. Plant Resour. 3, 37\u201342 (2013).","journal-title":"J. Nat. Prod. Plant Resour."},{"key":"35676_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.852889","volume":"12","author":"AM Huffman","year":"2022","unstructured":"Huffman, A. M., Ayariga, J. A., Napier, A., Robertson, B. K. & Abugri, D. A. Inhibition of Toxoplasma gondii growth by dihydroquinine and its mechanisms of action. Front. Cell. Infect. Microbiol. 12, 852889 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"35676_CR29","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3389\/fmicb.2019.02152","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang, J., Si, H., Li, B., Zhou, X. & Zhang, J. Myrislignan exhibits activities against Toxoplasma gondii RH strain by triggering mitochondrial dysfunction. Front. Microbiol. 10, 2152 (2019).","journal-title":"Front. Microbiol."},{"key":"35676_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpddr.2018.12.004","volume":"9","author":"JL Zhang","year":"2019","unstructured":"Zhang, J. L. et al. New life for an old drug. In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain. Int. J. Parasitol. Drugs Drug Resist. 9, 27\u201334 (2019).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"35676_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.684393","volume":"9","author":"JL Zhang","year":"2021","unstructured":"Zhang, J. L. et al. Licarin-B exhibits activity against the Toxoplasma gondii RH strain by damaging mitochondria and activating autophagy. Front. Cell. Dev. Biol. 9, 684393 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"35676_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/biomedicines9080934","volume":"9","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Anti-Toxoplasma gondii effects of a novel spider peptide XYP1 in vitro and in vivo. Biomedicines 9, 934 (2021).","journal-title":"Biomedicines"},{"key":"35676_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.parint.2017.10.010","volume":"67","author":"AG Sanford","year":"2018","unstructured":"Sanford, A. G. et al. Novel Toxoplasma gondii inhibitor chemotypes. Parasitol. Int. 67, 107\u2013111 (2018).","journal-title":"Parasitol. Int."},{"key":"35676_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12639-019-01185-5","volume":"44","author":"DA Abugri","year":"2020","unstructured":"Abugri, D. A. & Witola, W. H. Interaction of apigenin-7-O-glucoside with pyrimethamine against Toxoplasma gondii growth. J. Parasit. Dis. 44, 221\u2013229 (2020).","journal-title":"J. Parasit. Dis."},{"key":"35676_CR35","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.3390\/molecules24183307","volume":"24","author":"M Bu","year":"2019","unstructured":"Bu, M. et al. Synthesis of ergosterol peroxide conjugates as mitochondria targeting probes for enhanced anticancer activity. Molecules 24, 3307 (2019).","journal-title":"Molecules"},{"key":"35676_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1248\/bpb.29.755","volume":"29","author":"M Kobori","year":"2006","unstructured":"Kobori, M., Yoshida, M., Ohnishi-Kameyama, M., Takei, T. & Shinmoto, H. 5\u03b1, 8\u03b1-epidioxy-22E-ergosta-6, 9 (11), 22-trien-3\u03b2-ol from an edible mushroom suppresses growth of HL60 leukemia and HT29 colon adenocarcinoma cells. Biol. Pharm. Bull. 29, 755\u2013759 (2006).","journal-title":"Biol. Pharm. Bull."},{"key":"35676_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.vetpar.2010.11.034","volume":"177","author":"\u00c9S Martins-Duarte","year":"2011","unstructured":"Martins-Duarte, \u00c9. S. et al. Evaluation of three novel azasterols against Toxoplasma gondii. Vet. Parasitol. 177, 157\u2013161 (2011).","journal-title":"Vet. Parasitol."},{"key":"35676_CR38","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ijantimicag.2003.11.005","volume":"23","author":"L Dantas-Leite","year":"2004","unstructured":"Dantas-Leite, L., Urbina, J. A., de Souza, W. & Vommaro, R. C. Selective anti-Toxoplasma gondii activities of azasterols. Int. J. Antimicrob. Agents 23, 620\u2013626 (2004).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"35676_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/AAC.46.2.487-499.2002","volume":"46","author":"JC Rodrigues","year":"2002","unstructured":"Rodrigues, J. C., Attias, M., Rodriguez, C., Urbina, J. A. & Souza, W. D. Ultrastructural and biochemical alterations induced by 22, 26-azasterol, a \u039424 (25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob. Agents Chemother. 46, 487\u2013499 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"35676_CR40","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1021\/jm021114j","volume":"46","author":"F Magaraci","year":"2003","unstructured":"Magaraci, F. et al. Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi. J. Med. Chem. 46, 4714\u20134727 (2003).","journal-title":"J. Med. Chem."},{"key":"35676_CR41","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1021\/jm060290f","volume":"49","author":"L Gros","year":"2006","unstructured":"Gros, L. et al. Evaluation of azasterols as anti-parasitics. J. Med. Chem. 49, 6094\u20136103 (2006).","journal-title":"J. Med. Chem."},{"key":"35676_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbrc.2007.08.174","volume":"363","author":"C Maia","year":"2007","unstructured":"Maia, C. et al. Azasterols impair Giardia lamblia proliferation and induces encystation. Biochem. Biophys. Res. Commun. 363, 310\u2013316 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"35676_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1083\/jcb.149.1.167","volume":"149","author":"I Coppens","year":"2000","unstructured":"Coppens, I., Sinai, A. P. & Joiner, K. A. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 149, 167\u2013180 (2000).","journal-title":"J. Cell Biol."},{"key":"35676_CR44","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/ptr.5474","volume":"29","author":"T Meza-Menchaca","year":"2015","unstructured":"Meza-Menchaca, T., Su\u00e1rez-Medell\u00edn, J., Del \u00c1ngel-Pi\u00f1a, C. & Trigos, \u00c1. The amoebicidal effect of ergosterol peroxide isolated from Pleurotus ostreatus. Phytother. Res. 29, 1982\u20131986 (2015).","journal-title":"Phytother. Res."},{"key":"35676_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2021.109068","volume":"257","author":"C Duan","year":"2021","unstructured":"Duan, C., Liu, Y., Hao, Z. & Wang, J. Ergosterol peroxide suppresses porcine deltacoronavirus (PDCoV)-induced autophagy to inhibit virus replication via p38 signaling pathway. Vet. Microbiol. 257, 109068 (2021).","journal-title":"Vet. Microbiol."},{"key":"35676_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-021-00955-5","volume":"52","author":"C Duan","year":"2021","unstructured":"Duan, C. et al. Antiviral effects of ergosterol peroxide in a pig model of porcine deltacoronavirus (PDCoV) infection involve modulation of apoptosis and tight junction in the small intestine. Vet. Res. 52, 1\u201313 (2021).","journal-title":"Vet. Res."},{"key":"35676_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.fitote.2013.05.021","volume":"89","author":"Q Zhang","year":"2013","unstructured":"Zhang, Q. et al. The H+\/K+-ATPase inhibitory activities of trametenolic acid B from Trametes lactinea (Berk) Pat, and its effects on gastric cancer cells. Fitoterapia 89, 210\u2013217 (2013).","journal-title":"Fitoterapia"},{"key":"35676_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/znc-2001-1-208","volume":"56","author":"C Mart\u00edn-Cordero","year":"2001","unstructured":"Mart\u00edn-Cordero, C., Reyes, M., Ayuso, M. J. & Toro, V. Cytotoxic triterpenoids from Erica andevalensis. Zeitschrift f\u00fcr Naturforschung C. 56, 45\u201348 (2001).","journal-title":"Zeitschrift f\u00fcr Naturforschung C."},{"key":"35676_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fpubh.2017.00304","volume":"5","author":"A Prosperini","year":"2017","unstructured":"Prosperini, A. et al. A review of the mycotoxin enniatin B. Front. Public Health 5, 304 (2017).","journal-title":"Front. Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35676-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T06:07:37Z","timestamp":1685340457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35676-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35676-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,29]]},"assertion":[{"value":"2 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8667"}}